VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus

NCT01528254 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2004

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Placebo of vildagliptin
DRUG: vildagliptin
DRUG: Metformin

Sponsor

Novartis Pharmaceuticals